vs
Hims & Hers Health, Inc.（HIMS）与Teladoc Health, Inc.（TDOC）财务数据对比。点击上方公司名可切换其他公司
Teladoc Health, Inc.的季度营收约是Hims & Hers Health, Inc.的1.0倍（$642.3M vs $617.8M）。Hims & Hers Health, Inc.同比增速更快（28.4% vs 0.3%）。Teladoc Health, Inc.自由现金流更多（$85.1M vs $-2.5M）。过去两年Hims & Hers Health, Inc.的营收复合增速更高（49.0% vs -0.3%）
Hims & Hers Health, Inc.是2017年成立的美国远程医疗企业，面向消费者提供处方药品、非处方药物以及各类个人护理产品，依托线上服务模式为用户打造便捷的健康消费渠道，覆盖日常医疗、个护等多场景需求。
泰莱达克健康是一家跨国远程医疗与虚拟医疗企业，2002年成立，总部位于美国纽约。公司核心业务涵盖远程问诊、医学意见咨询、人工智能与数据分析、远程医疗设备及可授权平台服务，主要通过电话、视频会议软件与移动应用，为用户提供随时可及的远程医疗服务。
HIMS vs TDOC — 直观对比
营收规模更大
TDOC
是对方的1.0倍
$617.8M
营收增速更快
HIMS
高出28.1%
0.3%
自由现金流更多
TDOC
多$87.6M
$-2.5M
两年增速更快
HIMS
近两年复合增速
-0.3%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $617.8M | $642.3M |
| 净利润 | $20.6M | — |
| 毛利率 | 71.9% | — |
| 营业利润率 | 1.5% | -5.6% |
| 净利率 | 3.3% | — |
| 营收同比 | 28.4% | 0.3% |
| 净利润同比 | -20.8% | — |
| 每股收益（稀释后） | $0.08 | $-0.14 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HIMSTDOC
| Q4 25 | $617.8M | $642.3M | ||
| Q3 25 | $599.0M | $626.4M | ||
| Q2 25 | $544.8M | $631.9M | ||
| Q1 25 | $586.0M | $629.4M | ||
| Q4 24 | $481.1M | $640.5M | ||
| Q3 24 | $401.6M | $640.5M | ||
| Q2 24 | $315.6M | $642.4M | ||
| Q1 24 | $278.2M | $646.1M |
净利润HIMSTDOC
| Q4 25 | $20.6M | — | ||
| Q3 25 | $15.8M | $-49.5M | ||
| Q2 25 | $42.5M | $-32.7M | ||
| Q1 25 | $49.5M | $-93.0M | ||
| Q4 24 | $26.0M | — | ||
| Q3 24 | $75.6M | $-33.3M | ||
| Q2 24 | $13.3M | $-837.7M | ||
| Q1 24 | $11.1M | $-81.9M |
毛利率HIMSTDOC
| Q4 25 | 71.9% | — | ||
| Q3 25 | 73.8% | — | ||
| Q2 25 | 76.4% | — | ||
| Q1 25 | 73.5% | — | ||
| Q4 24 | 76.8% | — | ||
| Q3 24 | 79.2% | — | ||
| Q2 24 | 81.3% | — | ||
| Q1 24 | 82.4% | — |
营业利润率HIMSTDOC
| Q4 25 | 1.5% | -5.6% | ||
| Q3 25 | 2.0% | -8.3% | ||
| Q2 25 | 4.9% | -8.6% | ||
| Q1 25 | 9.9% | -19.2% | ||
| Q4 24 | 3.9% | -7.5% | ||
| Q3 24 | 5.6% | -6.9% | ||
| Q2 24 | 3.5% | -130.9% | ||
| Q1 24 | 3.6% | -13.5% |
净利率HIMSTDOC
| Q4 25 | 3.3% | — | ||
| Q3 25 | 2.6% | -7.9% | ||
| Q2 25 | 7.8% | -5.2% | ||
| Q1 25 | 8.4% | -14.8% | ||
| Q4 24 | 5.4% | — | ||
| Q3 24 | 18.8% | -5.2% | ||
| Q2 24 | 4.2% | -130.4% | ||
| Q1 24 | 4.0% | -12.7% |
每股收益（稀释后）HIMSTDOC
| Q4 25 | $0.08 | $-0.14 | ||
| Q3 25 | $0.06 | $-0.28 | ||
| Q2 25 | $0.17 | $-0.19 | ||
| Q1 25 | $0.20 | $-0.53 | ||
| Q4 24 | $0.10 | $-0.27 | ||
| Q3 24 | $0.32 | $-0.19 | ||
| Q2 24 | $0.06 | $-4.92 | ||
| Q1 24 | $0.05 | $-0.49 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $228.6M | $781.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $540.9M | $1.4B |
| 总资产 | $2.2B | $2.9B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资HIMSTDOC
| Q4 25 | $228.6M | $781.1M | ||
| Q3 25 | $345.8M | $726.2M | ||
| Q2 25 | $1.1B | $679.6M | ||
| Q1 25 | $273.7M | $1.2B | ||
| Q4 24 | $220.6M | $1.3B | ||
| Q3 24 | $165.5M | $1.2B | ||
| Q2 24 | $129.3M | $1.2B | ||
| Q1 24 | $105.2M | $1.1B |
股东权益HIMSTDOC
| Q4 25 | $540.9M | $1.4B | ||
| Q3 25 | $581.0M | $1.4B | ||
| Q2 25 | $562.7M | $1.4B | ||
| Q1 25 | $549.3M | $1.4B | ||
| Q4 24 | $476.7M | $1.5B | ||
| Q3 24 | $440.1M | $1.5B | ||
| Q2 24 | $362.0M | $1.5B | ||
| Q1 24 | $344.5M | $2.3B |
总资产HIMSTDOC
| Q4 25 | $2.2B | $2.9B | ||
| Q3 25 | $2.2B | $2.9B | ||
| Q2 25 | $1.9B | $2.9B | ||
| Q1 25 | $891.7M | $3.4B | ||
| Q4 24 | $707.5M | $3.5B | ||
| Q3 24 | $602.3M | $3.5B | ||
| Q2 24 | $480.5M | $3.5B | ||
| Q1 24 | $448.1M | $4.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $61.3M | $87.7M |
| 自由现金流经营现金流 - 资本支出 | $-2.5M | $85.1M |
| 自由现金流率自由现金流/营收 | -0.4% | 13.3% |
| 资本支出强度资本支出/营收 | 10.3% | 0.4% |
| 现金转化率经营现金流/净利润 | 2.98× | — |
| 过去12个月自由现金流最近4个季度 | $57.4M | $285.5M |
8季度趋势，按日历期对齐
经营现金流HIMSTDOC
| Q4 25 | $61.3M | $87.7M | ||
| Q3 25 | $148.7M | $99.3M | ||
| Q2 25 | $-19.1M | $91.4M | ||
| Q1 25 | $109.1M | $15.9M | ||
| Q4 24 | $86.4M | $85.9M | ||
| Q3 24 | $85.3M | $110.2M | ||
| Q2 24 | $53.6M | $88.7M | ||
| Q1 24 | $25.8M | $8.9M |
自由现金流HIMSTDOC
| Q4 25 | $-2.5M | $85.1M | ||
| Q3 25 | $79.3M | $97.0M | ||
| Q2 25 | $-69.5M | $90.2M | ||
| Q1 25 | $50.1M | $13.2M | ||
| Q4 24 | $59.5M | $79.8M | ||
| Q3 24 | $79.4M | $108.6M | ||
| Q2 24 | $47.6M | $86.8M | ||
| Q1 24 | $11.8M | $7.8M |
自由现金流率HIMSTDOC
| Q4 25 | -0.4% | 13.3% | ||
| Q3 25 | 13.2% | 15.5% | ||
| Q2 25 | -12.8% | 14.3% | ||
| Q1 25 | 8.5% | 2.1% | ||
| Q4 24 | 12.4% | 12.5% | ||
| Q3 24 | 19.8% | 17.0% | ||
| Q2 24 | 15.1% | 13.5% | ||
| Q1 24 | 4.3% | 1.2% |
资本支出强度HIMSTDOC
| Q4 25 | 10.3% | 0.4% | ||
| Q3 25 | 11.6% | 0.4% | ||
| Q2 25 | 9.3% | 0.2% | ||
| Q1 25 | 10.1% | 0.4% | ||
| Q4 24 | 5.6% | 1.0% | ||
| Q3 24 | 1.5% | 0.2% | ||
| Q2 24 | 1.9% | 0.3% | ||
| Q1 24 | 5.0% | 0.2% |
现金转化率HIMSTDOC
| Q4 25 | 2.98× | — | ||
| Q3 25 | 9.43× | — | ||
| Q2 25 | -0.45× | — | ||
| Q1 25 | 2.20× | — | ||
| Q4 24 | 3.32× | — | ||
| Q3 24 | 1.13× | — | ||
| Q2 24 | 4.03× | — | ||
| Q1 24 | 2.32× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HIMS
暂无分部数据
TDOC
| Teladoc Health Integrated Care | $409.1M | 64% |
| Better Help | $233.2M | 36% |
